Mackenzie Financial Corp Acquires 23,080 Shares of KKR & Co. Inc. (NYSE:KKR)

Mackenzie Financial Corp raised its holdings in KKR & Co. Inc. (NYSE:KKR) by 58.8% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 62,344 shares of the asset manager’s stock after buying an additional 23,080 shares during the period. Mackenzie Financial Corp’s holdings in KKR & Co. Inc. were worth $6,561,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in KKR. Bank of Nova Scotia raised its stake in KKR & Co. Inc. by 2,113.9% in the 4th quarter. Bank of Nova Scotia now owns 163,386 shares of the asset manager’s stock valued at $13,536,000 after acquiring an additional 156,006 shares during the period. CWA Asset Management Group LLC lifted its stake in shares of KKR & Co. Inc. by 0.9% during the 4th quarter. CWA Asset Management Group LLC now owns 12,310 shares of the asset manager’s stock worth $1,020,000 after buying an additional 114 shares during the last quarter. Cornerstone Advisory LLC bought a new stake in shares of KKR & Co. Inc. during the 4th quarter worth about $256,000. Belpointe Asset Management LLC acquired a new position in KKR & Co. Inc. in the 4th quarter valued at about $263,000. Finally, Spinecap SAS bought a new position in KKR & Co. Inc. in the 4th quarter valued at about $14,914,000. 76.26% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the company’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the transaction, the insider now owns 25,260,971 shares of the company’s stock, valued at $650,470,003.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, major shareholder Kkr Group Partnership L.P. bought 11,619,998 shares of the business’s stock in a transaction on Wednesday, September 11th. The shares were purchased at an average cost of $11.13 per share, with a total value of $129,330,577.74. Following the acquisition, the insider now owns 92,959,984 shares of the company’s stock, valued at $1,034,644,621.92. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the sale, the insider now directly owns 25,260,971 shares of the company’s stock, valued at approximately $650,470,003.25. The disclosure for this sale can be found here. Insiders own 39.34% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. JMP Securities upped their target price on KKR & Co. Inc. from $115.00 to $135.00 and gave the company a “market outperform” rating in a research report on Thursday, August 1st. The Goldman Sachs Group upped their price objective on KKR & Co. Inc. from $123.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 1st. TD Cowen lifted their target price on KKR & Co. Inc. from $145.00 to $154.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. Evercore ISI upped their price target on shares of KKR & Co. Inc. from $112.00 to $117.00 and gave the company an “outperform” rating in a research note on Monday, July 15th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of KKR & Co. Inc. from $128.00 to $141.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $128.27.

KKR & Co. Inc. Stock Down 1.2 %

NYSE KKR opened at $130.57 on Tuesday. The business has a fifty day moving average price of $120.55 and a two-hundred day moving average price of $109.09. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.07 and a quick ratio of 0.07. KKR & Co. Inc. has a fifty-two week low of $53.72 and a fifty-two week high of $134.85. The stock has a market capitalization of $115.87 billion, a PE ratio of 29.28, a PEG ratio of 1.11 and a beta of 1.62.

KKR & Co. Inc. (NYSE:KKR) last posted its quarterly earnings results on Wednesday, July 31st. The asset manager reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.20. The company had revenue of $4.17 billion for the quarter, compared to the consensus estimate of $1.07 billion. KKR & Co. Inc. had a net margin of 17.99% and a return on equity of 5.05%. During the same period last year, the company posted $0.58 EPS. Equities analysts expect that KKR & Co. Inc. will post 3.99 earnings per share for the current fiscal year.

KKR & Co. Inc. Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, August 27th. Shareholders of record on Monday, August 12th were given a $0.175 dividend. The ex-dividend date was Monday, August 12th. This represents a $0.70 annualized dividend and a yield of 0.54%. KKR & Co. Inc.’s dividend payout ratio is presently 15.70%.

KKR & Co. Inc. Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.